Two competing paths are emerging for monetizing GenAI in healthcare: one led by tech firms and FDA approvals, the other by clinicians empowering patients directly.
Related Posts
Data-driven creative solutions that include bioplastics are key to finding a way to succeed in crafting a new international environmental…
Meta’s chatbot failures reveal why “ship fast, fix later” is lethal. The future of AI will be built on trust,…
AI Fail: YouTube heard “Merz” but wrote “Merkel.” AI predicts averages, not truth—reminding us that human judgment, not blind trust,…
Looking for help with today’s New York Times Wordle? Here are some expert hints, clues and commentary to help you…
Though Hurricane Erin will not make landfall in the U.S., here’s why a tropical storm watch has been issued for…
Do you feel like your family drives you crazy and is impossible to deal with? Freakier Friday brings back waves…
Vertical hollow open-topped pipes used as property markers, fence posts and irrigation standpipes are killing countless wildlife across the United…
Happy couples aren’t conflict-free. They’re conflict-capable. They understand that arguments can actually deepen rather than damage relationships. Here’s how you…
Hacksmith’s new multi-tool proves creators can build more than audiences. With $7.4M raised and two weeks to go, the internet…
Dark Sky International, a nonprofit dedicated to raising awareness of the impacts of light pollution, shares the winners of its…